Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Sexually transmitted diseases (STDs) encompass more than 20 different infections that spread through the exchange of bodily fluids, such as semen and blood, or through direct contact with affected areas on individuals with an STD.
Also referred to as venereal diseases, STDs pose the highest risk to young women.
The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection.
This test is indicated as an aid in the diagnosis of specific agents of gastrointestinal illness, in conjunction with other clinical, laboratory, and epidemiological information; however, is not to be used to monitor these infections.
The test also aids in the detection and identification of acute gastroenteritis in the context of outbreaks.
Designed to detect the presence of key infections, including Hepatitis B (HBV), Hepatitis C (HCV), and HIV.
Early detection allows for timely treatment, reduces the risk of transmission, and helps protect your long-term health.
With advanced genetic testing methods, we provide fast, accurate, and confidential results, empowering you to take control of your well-being.
Many STDs present few or overlapping symptoms, making clinical diagnosis challenging and often unreliable. However, recent advancements in diagnostic testing, especially at the molecular level, have greatly enhanced the accuracy of detection. Consequently, laboratory investigations now play a crucial role in the definitive diagnosis of STDs.
However, the following symptoms might present:
Laboratory tests are used to diagnose sexually transmitted diseases (STDs). Below are some common types of STDs:
The respiratory virus panel is used for the detection of many respiratory viruses including:
The results of this assay should be used in conjunction with other clinical and laboratory
findings.
Acute diarrhea caused by bacterial and viral infection represents a significant worldwide healthcare burden. The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The gastrointestinal pathogen panel is used for the detection of many gastro viruses including:
This test is intended for use in conjunction with clinical presentation and other laboratory markers for the clinical management of patients with chronic HBV infection undergoing antiviral therapy. The test can be used to measure HBV DNA levels at baseline and during treatment to aid in assessing response to treatment.
The cobas® HBV Test is not intended for use as a screening test for the presence of
HBV in blood or blood products or as a diagnostic test to confirm the presence of HBV
infection.
Reportable range is 10 to 1,000,000,000 IU/mL (1.00 to 9.00 Log IU/mL).
Clinical Significance:
This test is useful in monitoring therapy and/or disease progression.
Reportable range is 15 to 100,000,000 IU/mL (1.18-8.00 log IU/mL)
Clinical Significance:
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients.
The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of antiretroviral treatment.
Alternative Name(s):
HIV-1 RNA, QN, PCR, Viral Load, HIV, HIV Viral Load
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.